Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.

Browne, Patience; Noyes, Pamela D; Casey, Warren M; Dix, David J

Browne, Patience; Noyes, Pamela D; Casey, Warren M; Dix, David J.

Afiliación

Browne P; Office of Chemical Safety and Pollution Prevention, U.S. Environmental Protection Agency , Washington, DC, USA.
Noyes PD; Office of Chemical Safety and Pollution Prevention, U.S. Environmental Protection Agency , Washington, DC, USA.
Casey WM; National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services , Research Triangle Park, North Carolina, USA.
Dix DJ; Office of Chemical Safety and Pollution Prevention, U.S. Environmental Protection Agency , Washington, DC, USA.

Environ Health Perspect ; 125(9): 096001, 2017 09 01.

Article en En | MEDLINE | ID: mdl-28934726

Asunto(s)

Disruptores Endocrinos/toxicidad; Pruebas de Toxicidad/métodos; United States Environmental Protection Agency; Bioensayo; Programas de Gobierno; Pruebas de Toxicidad/normas; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: United States Environmental Protection Agency / Pruebas de Toxicidad / Disruptores Endocrinos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Environ Health Perspect Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google